Search results
Results from the WOW.Com Content Network
Poppers is an inhaled drug which contains a range of alkyl nitrites, such as isobutyl nitrite and amyl nitrite. [11] Despite its primary usage as a potent vasodilator , [ 11 ] its popularity among the homosexual community largely stems from its ability to facilitate anal sexual intercourse by relaxing the smooth muscles in the internal anal ...
The most common side effect is conjunctival hyperaemia (increased bloodflow in the outer layer of the eye), which occurs in over 10% of people taking the drug. Side effects in less than 10% of people include other eye problems such as itching, foreign body sensation or dry eye, as headache or hyperpigmentation (darkening) of the skin around the eye.
The most prevalent research on prescription drugs with side effects of macropsia deals with zolpidem and citalopram. Zolpidem is a drug prescribed for insomnia, and although it has proven beneficial effects, there have been numerous reported cases of adverse perceptual reactions. [ 13 ]
These medications mimic a protein in your body called glucagon-like peptide 1 (or GLP-1), explains Mir Ali, M.D., a bariatric surgeon and medical director of MemorialCare Surgical Weight Loss ...
Hallucinogen persisting perception disorder (HPPD) is a non-psychotic disorder in which a person experiences apparent lasting or persistent visual hallucinations or perceptual distortions after using drugs, [1] including but not limited to psychedelics, dissociatives, entactogens, tetrahydrocannabinol (THC), and SSRIs.
In the process, metabolites, or byproducts, of the drug are produced, which can linger in our blood, urine (and even in our hair) for long after the initial effects of the drug are felt.
A new study, which appeared in JAMA Ophthalmology earlier this week, identified a potential link between the diabetes and weight loss drug, semaglutide and a rare eye disease that causes blindness.
These side effects are serious and some of them are permanent, and many remain a crucial concern for companies and healthcare professionals and substantial efforts are being encouraged to reduce the potential risks for future antipsychotics through more clinical trials and drug development.